The U.S. is the most expensive place to have Type 2 diabetes, with an average lifetime price tag of $283,000, according to a new study published in the journal PharmacoEconomics.

Researchers at the University of East Anglia (UEA) analyzed 109 studies on the economic impact of Type 2 diabetes and found that costs are higher in the U.S., even compared with other countries with similar income levels.

Get The Brief. Sign up to receive the top stories you need to know right now. Please enter a valid email address. Sign Up Now Check the box if you do not wish to receive promotional offers via email from TIME. You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy . This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Thank you! For your security, we've sent a confirmation email to the address you entered. Click the link to confirm your subscription and begin receiving our newsletters. If you don't get the confirmation within 10 minutes, please check your spam folder.

“Employment chances for women with diabetes in the U.S. are decreased by almost half,” said study author Till Seuring of UEA’s Norwich Medical School in a statement. “Women with diabetes also lose out on $21,392 in earnings per year — the highest loss due to diabetes worldwide,” In other countries, men with diabetes suffer more when it comes to employment options, the data shows.

Still, the U.S. appears to be an exception. Diabetes has the greatest economic toll for people in low- and middle-income countries, the research finds. Most new cases are appearing in countries in this economic stratum, including Mexico, India and China.

Diabetes affects over 380 million people worldwide, the researchers say. That number is expected to balloon to 592 million people by 2035.

Check out the findings in the infographic below.

University of East Anglia

Read next: What Diet Soda Does to Belly Fat

Listen to the most important stories of the day.

Contact us at letters@time.com.